# LifeSci Capital

> LifeSci Capital is a VC fund backing Biotechnology and Medical Device. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 2
- Last investment: Mar 2025
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lifesci-capital-llc
- Website: https://lifescicapital.com

LifeSci Capital is a research-driven investment bank company.

## Contacts

5 contacts available for LifeSci Capital. Shizune tracks 2 team members at LifeSci Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lifesci-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical Device | 2 | 100% |
| Medical | 1 | 50% |
| Software | 1 | 50% |
| Biopharma | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Post-IPO Equity | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 50% |
| United Kingdom | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adam Evertts | Senior Research Analyst | 0 | — |
| Hany Awadalla | Managing Director and Head of Investment Banking | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brainomix | Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time. | $18.2M | Series C | Mar 18, 2025 |  |
| InspireMD | InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology tomake its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis.InspireMD intends to pursue applications of its innovative technology both for bare metal and drug eluting stents in coronary, carotid and peripheral artery procedures. | $113.6M | Post-IPO Equity | May 15, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Parkwalk Advisors](https://shizune.co/investors/profile/parkwalk-advisors) — VC Fund, 2 deals together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 1 deal together
- [Marshall Wace](https://shizune.co/investors/profile/marshall-wace) — VC Fund, 1 deal together
- [Nantahala Capital Management](https://shizune.co/investors/profile/nantahala-capital-management) — VC Fund, 1 deal together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does LifeSci Capital invest in?

LifeSci Capital invests primarily in Biotechnology, Medical Device and Medical startups, most often at Series C and Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact LifeSci Capital?

Public channels for LifeSci Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LifeSci Capital?

The team at LifeSci Capital includes Adam Evertts (Senior Research Analyst) and Hany Awadalla (Managing Director and Head of Investment Banking). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co